Immune thrombocytopenia
ITP and its newer treatments.
Key point
Adult ITP care incorporates newer thrombopoietin receptor agonists and small molecule kinase inhibitors, emphasizing thrombotic risk and quality of life.
From: [Chinese guideline on the diagnosis and treatment of adult primary immune thrombocytopenia (2025)] (Zhonghua Xue Ye Xue Za Zhi, 2025 Dec 14) ↗Papers per year
Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 110, 94, 106, 113, 92.
New guidelines and consensus this year
- Response to: citation clarification regarding feline eltrombopag in the ACVIM consensus statement on the treatment of immune thrombocytopenia in dogs and catsJ Vet Intern Med2026 Sep 1
- Citation clarification regarding feline eltrombopag in the "ACVIM consensus statement on the treatment of immune thrombocytopenia in dogs and cats"J Vet Intern Med2026 Sep 1
- [Chinese guideline on the diagnosis and treatment of adult primary immune thrombocytopenia (2025)]Zhonghua Xue Ye Xue Za Zhi2025 Dec 14
All papers from the last 12 months
683 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…
- In-vitro diagnostics of adult immune thrombocytopenia - status quo and new developmentsClin Chim Acta2027 Jan 1PMID 42269737Review
- Sirolimus-based treatment regimens for antinuclear antibody (ANA)-positive immune thrombocytopenia: a retrospective single-center cohort studyHematology2026 Dec 31PMID 42179326
- Persistent Immune Thrombocytopenia as a Post-Acute Sequelae of COVID-19: A Case ReportPublic Health Chall2026 DecPMID 42845832
- Real-world safety data of human papillomavirus vaccines after marketing in Shandong, China, August 2017-October 2025Hum Vaccin Immunother2026 DecPMID 42788243
- Effects of serum vitamin D on platelet function and bleeding in primary immune thrombocytopeniaPlatelets2026 DecPMID 42733345
- Durable platelet response and immature platelet indices following sequential efgartigimod and eltrombopag therapy in a patient with refractory ITPPlatelets2026 DecPMID 42517215
- Atypical Wiskott-Aldrich syndrome presenting with normal platelet volume and end-stage renal disease: from misdiagnosis as ITP to combined transplantationJ Transl Autoimmun2026 DecPMID 42394675
- Single-cell transcriptome deciphers key targets of thrombopoietin receptor agonists and immune microenvironment characteristics of immune thrombocytopeniaPlatelets2026 DecPMID 41918402
- Abnormal expansion of peripheral helper T cells in primary immune thrombocytopeniaPlatelets2026 DecPMID 41914348
- Hematologic adverse events following COVID-19 vaccination and revaccination in persons aged 12 and above: A Canadian Immunization Research Network studyHum Vaccin Immunother2026 DecPMID 41848549
More hematology trends
All specialties →Measurable residual disease
Detecting residual disease after treatment of blood cancers.
Gene therapy for sickle cell and thalassaemia
CRISPR-based and lentiviral gene therapies for haemoglobin disorders.
CAR-T in blood cancers
Chimeric antigen receptor T-cell therapy in lymphoma, myeloma and leukaemia.
Key point: CAR T-cell therapy has emerged as an effective option for refractory or progressive mantle cell lymphoma after prior covalent BTK inhibitor treatment.
DOACs in cancer-associated thrombosis
Direct oral anticoagulants for venous thromboembolism in people with cancer.
Myelofibrosis treatment
JAK inhibitors and newer drugs in myelofibrosis.
Key point: Ruxolitinib-based combination regimens showed improved spleen and symptom responses with acceptable safety, with efficacy significantly influenced by prior JAK inhibitor exposure.
Post-transplant cyclophosphamide
Cyclophosphamide after stem cell transplant to prevent graft-versus-host disease.
Key point: Post-transplant cyclophosphamide appears to reduce graft-versus-host disease without increasing relapse or mortality in matched related donor transplantation for acute leukemia.
Too many papers to read?
PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.
How these numbers are counted
PubMed query, searched in titles and abstracts by publication date:
"immune thrombocytopenia"[tiab]Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.